Patient’s age and the dynamics of IgM for L. pneumophila sg1
Journal Title: Przegląd Epidemiologiczny - Year 2014, Vol 68, Issue 1
Abstract
MATERIAL AND METHODS. The results of IgM L. pneumophila sg1 test in 304 adults and 270 children performed at NIPH-NIH in 2004-2007 were analyzed to determine the effects of patients’ age and the interval between collected sera on the results and the interpretation. RESULTS. Significant difference in the level of IgM, depending on the age of the patients (Po = 0.0084) was found. Positive results (in total 20.4% of patients) were the most frequently observed in patients aged 19-29 years (42.5%), and the least - in patients 60 y.o. and <2 y.o. (7%). Average and median levels of IgM in these two groups (+60 y.o. and <2 y.o.) were similar and significantly different from the results in the other groups. From 44 adults and 33 children ≥ 2 sera were collected. There was a significant difference in the interval between collecting the first and second serum sample in adults (mainly 3-5 weeks) and children (mainly 2-4 weeks). Significant increase of IgM levels was observed in children when the interval between 1 and 2 sample didn’t exceed 4 weeks, while in adults this change was also observed at > 5 weeks (25% of patients). No significant differences in the analysis of the IgM ratio in children (1.25-14) and adults (1.5-26) was found, but longer persistence of IgM in adults than in children was observed. CONCLUSIONS. Demonstrated trend of faster decline in the level of IgM among children than in adults indicated that in suspected case of legionellosis in children, the serum sample should be taken up to 4-5 weeks after the onset, and at intervals of 1-2 weeks maximum.
Authors and Affiliations
Katarzyna Pancer
Keywords
Related Articles
- EP ID EP72582
- DOI -
- Views 64
- Downloads 0
Mumps in Poland in 2015 / Świnka w Polsce w 2015 roku
BACKGROUND: Vaccination against mumps from 2003 is mandatory in Poland and given as two dose scheme with MMR vaccine (mumps, measles, and rubella). Earlier this vaccination was only recommended. Despite observed decline...
Uzasadnienie wczesnego wprowadzenia terapii antyretrowirusowej u pacjentów żyjących z HIV
W ostatnich latach choroba retrowirusowa, wywołana zakażeniem ludzkim wirusem niedoboru odporności (HIV), z nieuleczalnej stała się chorobą przewlekłą. Ta istotna zmiana dokonała się dzięki postępowi wiedzy dotyczącej pa...
Hepatitis C in Poland in 2016 / Wirusowe zapalenie wątroby typu C w Polsce w 2016 roku
INTRODUCTION. In 2016, the World Health Organization implemented a Global Strategy to eliminate viral hepatitis. For Hepatitis C, the goals of this Strategy include increased harm reduction coverage, improved safety of m...
Ocena częstości występowania przeciwciał przeciw parwowirusowi B19 u kobiet będących w ciąży lub planujących ciążę, badanych w kierunku toksoplazmozy
WSTĘP I CEL PRACY. Zakażenie parwowirusem B19 (B19V) stanowi udowodnione zagrożenie dla kobiet w ciąży i płodu. Celem pracy było retrospektywne oznaczenie obecności przeciwciał w surowicy przeciw B19V wśród kobiet w ciąż...
Campylobacteriosis in Poland in 2015 and 2016 / Kampylobakterioza w Polsce w 2015 i 2016 roku
OBJECTIVE: The aim of this study is to assess the epidemiological situation of campylobacteriosis in Poland in 2015 and 2016 in comparison to the previous years. MATERIAL AND METHODS: The evaluation is based on analysis...